Parnell Pharmaceuticals Holdings Stock Predictions

> Drug Manufacturers - Specialty & Generic

Buy PARNF

*Your capital is at risk

$0.0800

+0 (+0%)

At Close: Jul 21, 2025

Currently predicting for Mon, 15 Jun 2026

PARNF Live board

Community Bull/Bear

Target Next close

Join the PARNF prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

PARNF Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For PARNF

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

PARNF Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT PARNELL PHARMACEUTICALS HOLDINGS LTD.

Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for improving cattle breeding performa...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	13.43%	Jun 05
TPR $140.47	4.95%	Jun 04
LITE $905.00	1.83%	Jun 01
RUN $12.83	0.468%	May 06
GLBE $31.61	3.54%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by